search
Back to results

Comparison of Hemodynamic Results of Two Different Fluid Managements

Primary Purpose

Perioperative Fluid Management

Status
Recruiting
Phase
Not Applicable
Locations
Turkey
Study Type
Interventional
Intervention
isotonic solution
Noradrenaline
Sponsored by
Istanbul University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Perioperative Fluid Management focused on measuring fluid therapy, hemodynamic parameters, The pulse contour cardiac output system, inducible nitric oxide synthetase

Eligibility Criteria

18 Years - 65 Years (Adult, Older Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria: Volunteering to participate in the study ASA classification 1 or 2 The patients who will undergo reduction mammoplasty operation Exclusion Criteria: Being under the age of 18 or over the age of 65 Presence of serious hypertension

Sites / Locations

  • Istanbul University, Department of AnesthesiologyRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

Stroke Volume Variation (SVV) Group

Mean Arterial Pressure (MAP) Group

Arm Description

When SVV value ≥ 14%, 250cc isotonic will be given within 10min. 250cc isotonic boluses will be repeated until the SVV drops below 14%. If MAP< 65 mmHg despite the SVV falling below 14%, a bolus of 4mcg noradrenaline(NA) will be administered. During the operation, if the SVV is below 14% and the MAP is < 65mmHg, a bolus of 4mcg NA will be administered. Intraoperative balance, amount of bleeding, number of fluid boluses and NA administrations, total additional fluid and NA amount, total number of hypotensive episodes will be recorded. The times when the breast tissue was removed, the weights of the removed tissues and the amount of bleeding will be recorded. Basal and 3 more arterial blood gases will be taken when the breast tissue is removed and early postoperatively, and Hgb, lactate, and base excess values will be recorded. iNOS values in blood will be recorded after basal iNOS and breast tissue are removed. The creatinine value will be recorded on the 1st postoperative day.

If MAP value under below 65mmHg, 250ml isotonic will be given within 10 min. However, if MAP is still below 65mmHg, a bolus of 4mcg NA will be administered, if no response, 4mcg NA will be repeated. If MAP falls below 65mmHg again, 250 ml isotonic will be administered again in 10 min; if it does not improve, 4mcg of NA will be given iv. Intraoperative balance, amount of bleeding, number of fluid boluses and NA administrations, total additional fluid and NA amount, total number of hypotensive episodes will be recorded. The times when the breast tissue was removed, the weights of the removed tissues and the amount of bleeding will be recorded. Basal and 3 more arterial blood gases will be taken when the breast tissue is removed and early postoperatively, and Hgb, lactate, and base excess values will be recorded. iNOS values in blood will be recorded after basal iNOS and breast tissue are removed. The creatinine value will be recorded on the 1st postoperative day.

Outcomes

Primary Outcome Measures

Cardiac index
Cardiac index (CI) is a haemodynamic parameter that relates the cardiac output (CO) from left ventricle in one minute to body surface area (BSA),thus relating heart performance to the size of the individual. The unit of measurement is litres per minute per square metre (L/min/m2).

Secondary Outcome Measures

Number of bolus administrations of noradrenaline
For the MAP group, if MAP is still below 65 mmHg despite a bolus of 250ml isotonic fluid, a bolus of 4mcg noradrenaline will be administered, if no response, 4mcg noradrenaline will be repeated. For the SVV Group, a 4 mcg bolus of noradrenaline will be given if MAP< 65 mmHg despite the SVV falling below 14% with isotonic boluses.
Number of bolus administrations of isotonic fluid
For the MAP group, the number of administrations of 250 ml of isotonic fluid delivered in 10 minutes when MAP < 65 mmHg For the SVV group, the number of administrations of 250 ml of isotonic fluid administered in 10 minutes when SVV≥ 14%
The Number of Hypotensive Episodes
The number of times the MAP value falls below 65mmHg during surgery
Intraoperative Fluid Balance
the difference between the amount of urine output and the amount of bleeding from the amount of fluid given
Plasma iNOS Levels
difference in serum iNOS levels preoperatively and after removal of mammoplasty material
Lactate value
Values measured by perioperative arterial blood gas analysis
Base deficit value
Values measured by perioperative arterial blood gas analysis
Creatinine value
Blood level is checked on the preoperative and postoperative 1st day
Urea value
Blood level is checked on the preoperative and postoperative 1st day
Hemoglobin value
Blood level is checked on the preoperative and postoperative 1st day

Full Information

First Posted
October 28, 2022
Last Updated
October 20, 2023
Sponsor
Istanbul University
search

1. Study Identification

Unique Protocol Identification Number
NCT05733403
Brief Title
Comparison of Hemodynamic Results of Two Different Fluid Managements
Official Title
Comparison of Hemodynamic Results of Two Different Fluid Managements in Reduction Mammoplasty Operation
Study Type
Interventional

2. Study Status

Record Verification Date
October 2023
Overall Recruitment Status
Recruiting
Study Start Date
April 1, 2022 (Actual)
Primary Completion Date
October 20, 2023 (Actual)
Study Completion Date
December 1, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Istanbul University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
In the reduction mammoplasty operations performed in the Plastic and Reconstructive surgery operating room in our clinic, the female patient group, who does not have co-morbidities and does not exceed middle age, is followed by infusion of crystalloid at a constant rate of 4 ml/kg. If the mean arterial pressure (MAP) is <65 mmHg, it is treated with fluid boluses, and in cases where no response is obtained, with noradrenaline boluses. However, in this process, frequent and severe hypotensive episodes are observed, especially after removal of more than a few kilograms of breast tissue. In these hypotensive episodes, factors other than the blood volume lost with the tissue may also play a role. For this reason, we aimed to evaluate the iNOS levels by assuming that the blood levels of "inducible nitric oxide synthetase" (iNOS), which is stored in large amounts in adipose tissues and has been shown to play a role in lipid metabolism, may increase with the manipulation of breast tissue, and accordingly increased nitric oxide may lead to hypotension.
Detailed Description
The main purpose of intraoperative fluid therapy is to optimize intravascular volume, mean arterial pressure (MAP) and cardiac output, while ensuring tissue perfusion, while not causing dehydration and fluid overload in the patient. While hypovolemia may cause problems such as organ perfusion disorders and ischemia; Hypervolemia may lead to pulmonary edema, cardiac load, prolonged need for mechanical ventilation and susceptibility to related infections. Although fluid management in the perioperative period has been extensively studied in many studies, a standard practice has not been established. The amount considered restrictive in some studies may be liberal in others. In recent years, the use of dynamic parameters, which are formed as a result of cardiopulmonary interactions and whose high sensitivity and specificity have been proven by many studies, has been increasing day by day for the evaluation of intravascular volume. Pulse pressure variation(PPV) and stroke volume variation(SVV) are two of these dynamic parameters. The pulse contour cardiac output (FloTrac) system, which is a fairly newly developed method that calculates cardiac output and stroke volume directly from the arterial waveform, is used for measurement without the need for calibration. In the reduction mammoplasty operations performed in the Plastic and Reconstructive surgery operating room in our clinic, the female patient group, who does not have co-morbidities and does not exceed middle age, is followed by infusion of crystalloid at a constant rate of 4 ml/kg. If the mean arterial pressure (MAP) is <65 mmHg, it is treated with fluid boluses, and in cases where no response is obtained, with noradrenaline boluses. However, in this process, frequent and severe hypotensive episodes are observed, especially after removal of more than a few kilograms of breast tissue. In these hypotensive episodes, factors other than the blood volume lost with the tissue may also play a role. For this reason, we aimed to evaluate the iNOS levels by assuming that the blood levels of "inducible nitric oxide synthetase" (iNOS), which is stored in large amounts in adipose tissues and has been shown to play a role in lipid metabolism, may increase with the manipulation of breast tissue, and accordingly increased nitric oxide may lead to hypotension.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Perioperative Fluid Management
Keywords
fluid therapy, hemodynamic parameters, The pulse contour cardiac output system, inducible nitric oxide synthetase

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
40 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Stroke Volume Variation (SVV) Group
Arm Type
Active Comparator
Arm Description
When SVV value ≥ 14%, 250cc isotonic will be given within 10min. 250cc isotonic boluses will be repeated until the SVV drops below 14%. If MAP< 65 mmHg despite the SVV falling below 14%, a bolus of 4mcg noradrenaline(NA) will be administered. During the operation, if the SVV is below 14% and the MAP is < 65mmHg, a bolus of 4mcg NA will be administered. Intraoperative balance, amount of bleeding, number of fluid boluses and NA administrations, total additional fluid and NA amount, total number of hypotensive episodes will be recorded. The times when the breast tissue was removed, the weights of the removed tissues and the amount of bleeding will be recorded. Basal and 3 more arterial blood gases will be taken when the breast tissue is removed and early postoperatively, and Hgb, lactate, and base excess values will be recorded. iNOS values in blood will be recorded after basal iNOS and breast tissue are removed. The creatinine value will be recorded on the 1st postoperative day.
Arm Title
Mean Arterial Pressure (MAP) Group
Arm Type
Active Comparator
Arm Description
If MAP value under below 65mmHg, 250ml isotonic will be given within 10 min. However, if MAP is still below 65mmHg, a bolus of 4mcg NA will be administered, if no response, 4mcg NA will be repeated. If MAP falls below 65mmHg again, 250 ml isotonic will be administered again in 10 min; if it does not improve, 4mcg of NA will be given iv. Intraoperative balance, amount of bleeding, number of fluid boluses and NA administrations, total additional fluid and NA amount, total number of hypotensive episodes will be recorded. The times when the breast tissue was removed, the weights of the removed tissues and the amount of bleeding will be recorded. Basal and 3 more arterial blood gases will be taken when the breast tissue is removed and early postoperatively, and Hgb, lactate, and base excess values will be recorded. iNOS values in blood will be recorded after basal iNOS and breast tissue are removed. The creatinine value will be recorded on the 1st postoperative day.
Intervention Type
Drug
Intervention Name(s)
isotonic solution
Other Intervention Name(s)
0,9% NaCl
Intervention Description
Isotonic solutions are IV fluids that have a similar concentration of dissolved particles as blood.
Intervention Type
Drug
Intervention Name(s)
Noradrenaline
Other Intervention Name(s)
Norepinephrine
Intervention Description
Noradrenaline itself is classified as a sympathomimetic drug: its effects when given by intravenous injection of increasing heart rate and force and constricting blood vessels make it very useful for treating medical emergencies that involve critically low blood pressure.
Primary Outcome Measure Information:
Title
Cardiac index
Description
Cardiac index (CI) is a haemodynamic parameter that relates the cardiac output (CO) from left ventricle in one minute to body surface area (BSA),thus relating heart performance to the size of the individual. The unit of measurement is litres per minute per square metre (L/min/m2).
Time Frame
during surgery
Secondary Outcome Measure Information:
Title
Number of bolus administrations of noradrenaline
Description
For the MAP group, if MAP is still below 65 mmHg despite a bolus of 250ml isotonic fluid, a bolus of 4mcg noradrenaline will be administered, if no response, 4mcg noradrenaline will be repeated. For the SVV Group, a 4 mcg bolus of noradrenaline will be given if MAP< 65 mmHg despite the SVV falling below 14% with isotonic boluses.
Time Frame
during surgery
Title
Number of bolus administrations of isotonic fluid
Description
For the MAP group, the number of administrations of 250 ml of isotonic fluid delivered in 10 minutes when MAP < 65 mmHg For the SVV group, the number of administrations of 250 ml of isotonic fluid administered in 10 minutes when SVV≥ 14%
Time Frame
during surgery
Title
The Number of Hypotensive Episodes
Description
The number of times the MAP value falls below 65mmHg during surgery
Time Frame
during surgery
Title
Intraoperative Fluid Balance
Description
the difference between the amount of urine output and the amount of bleeding from the amount of fluid given
Time Frame
during surgery
Title
Plasma iNOS Levels
Description
difference in serum iNOS levels preoperatively and after removal of mammoplasty material
Time Frame
Up to 6 hours
Title
Lactate value
Description
Values measured by perioperative arterial blood gas analysis
Time Frame
Up to 6 hours
Title
Base deficit value
Description
Values measured by perioperative arterial blood gas analysis
Time Frame
Up to 6 hours
Title
Creatinine value
Description
Blood level is checked on the preoperative and postoperative 1st day
Time Frame
Preoperative and Postoperative 1st day
Title
Urea value
Description
Blood level is checked on the preoperative and postoperative 1st day
Time Frame
Preoperative and Postoperative 1st day
Title
Hemoglobin value
Description
Blood level is checked on the preoperative and postoperative 1st day
Time Frame
Preoperative and Postoperative 1st day

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Volunteering to participate in the study ASA classification 1 or 2 The patients who will undergo reduction mammoplasty operation Exclusion Criteria: Being under the age of 18 or over the age of 65 Presence of serious hypertension
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Demet Altun Bingol, Assoc. Prof.
Phone
902126318767
Email
drdemetaltun@hotmail.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ceren Yılmaz, Resident
Organizational Affiliation
Istanbul University
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Demet Kıvanç, researcher
Organizational Affiliation
Istanbul University
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Ali E Çamcı, Prof.
Organizational Affiliation
Istanbul University
Official's Role
Study Director
Facility Information:
Facility Name
Istanbul University, Department of Anesthesiology
City
Istanbul
State/Province
Fatih
ZIP/Postal Code
34093
Country
Turkey
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Demet Altun, MD
Phone
00905326811767
Email
drdemetaltun@hotmail.com

12. IPD Sharing Statement

Citations:
PubMed Identifier
22906292
Citation
Li J, Ji FH, Yang JP. Evaluation of stroke volume variation obtained by the FloTrac/Vigileo system to guide preoperative fluid therapy in patients undergoing brain surgery. J Int Med Res. 2012;40(3):1175-81. doi: 10.1177/147323001204000338.
Results Reference
result
PubMed Identifier
31672462
Citation
Anavi S, Tirosh O. iNOS as a metabolic enzyme under stress conditions. Free Radic Biol Med. 2020 Jan;146:16-35. doi: 10.1016/j.freeradbiomed.2019.10.411. Epub 2019 Oct 28.
Results Reference
result

Learn more about this trial

Comparison of Hemodynamic Results of Two Different Fluid Managements

We'll reach out to this number within 24 hrs